Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors

Accountability in Research

Volumn 12, Issue 3, 2005, Pages 163-191

  Mello, Michelle M ^a   Clarridge, Brian R ^b   Studdert, David M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Clinical trials; Conflict of interest; Drug industry; Publications standards; Research support

Indexed keywords

ADMINISTRATIVE PERSONNEL; ARTICLE; ATTITUDE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONFLICT OF INTEREST; CONTRACT; ECONOMICS; EMPIRICAL APPROACH; ETHICS; FINANCIAL MANAGEMENT; HUMAN; INDUSTRY; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MEDICAL SCHOOL; METHODOLOGY; PERSONNEL; POLICY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PUBLISHING; QUESTIONNAIRE; STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

ADMINISTRATIVE PERSONNEL; ATTITUDE; CLINICAL TRIALS; CONFLICT OF INTEREST; CONTRACTS; DATA COLLECTION; FACULTY, MEDICAL; GUIDELINES; HUMANS; INDUSTRY; INFORMATION DISSEMINATION; ORGANIZATIONAL POLICY; PUBLISHING; QUESTIONNAIRES; RESEARCH DESIGN; RESEARCH PERSONNEL; RESEARCH SUPPORT; SCHOOLS, MEDICAL; UNITED STATES;

EID: 33646854707     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989620500216380     Document Type: Article

References (34)

1. Association of American Medical Colleges (2004). Faculty Roster Support and Uses. Retrieved August 19, 2004. Available at http://www.aamc.org/data/ facultyroster/support.htm.
2. Angell, M. (2000). Is Academic Medicine for Sale?, N Engl J Med, 342(20): 1516-1518.
3. Bekelman, J. E., Li, Y., et al. (2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review, Jama, 289(4): 454-465.
4. Berk, R. A., Korenman, S. G. Wenger, N. S., et al. (2000). Measuring Consensus About Scientific Research Norms, Sci Eng Ethics, 6(3): 315-340.
5. Bero, L. A., and Rennie, D. (1996). Influences on the Quality of Published Drug Studies, Int J Technol Assess Health Care, 12(2): 209-237.
6. Blumenthal, D. (2003). Academic-Industrial Relationships in the Life Sciences, N Engl J Med, 349(25): 2452-2459.
7. Blumenthal, D., Campbell, E. G., Anderson, M. S., Causino, N., Louis, K. S., et al. (1997). Withholding Research Results in Academic Life Science. Evidence from a National Survey of Faculty, Jama, 277(15): 1224-1228.
8. Blumenthal, D., Campbell, E. G., Causino, N. Louis, K. S., et al. (1996). Participation of Life-Science Faculty in Research Relationships with Industry, N Engl J Med, 335(23): 1734-1739.
9. Blumenthal, D., Causino, N., Cambell, E., Louis, K. S., et al. (1996). Relationships Between Academic Institutions and Industry in the Life Sciences--An Industry Survey, N Engl J Med, 334(6): 368-373.
10. Bodenheimer, T. (2000). Uneasy Alliance--Clinical Investigators and the Pharmaceutical Industry, N Engl J Med, 342(20): 1539-1544.
11. Boyd, E. A., and Bero, L. A. (2000). Assessing Faculty Financial Relationships with Industry: A Case Study, Jama, 284(17): 2209-2214.
12. Boyd, E. A., Cho, M. K., Bero, L. A., et al. (2003). Financial Conflict-of-Interest Policies in Clinical Research: Issues for Clinical Investigators, Acad Med, 78(8): 769-774.
13. Cho, M. K., Shohara, R., Schissel, A., Rennie, D., et al. (2000). Policies on Faculty Conflicts of Interest at US Universities, Jama, 284(17): 2203-2208.
14. Cohen, W., Florida, R., Goe, W. R., et al. (1994). University-Industry Research Centers in the United States, Pittsburgh: Carnegie-Mellon University.
15. Drazen, J. M. (2002). Institutions, Contracts, and Academic Freedom, N Engl J Med, 347(17): 1362-1363.
16. DuVal, G. (2004). Institutional Ethics Review of Clinical Study Agreements, J Med Ethics, 30(1): 30-34.
17. Editors, International Committee of Medical Journals. (2004, October 2004). Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Retrieved January 25, 2005. Available at http://www.icmje.org.
18. Hilts, P. J. (2000). Drug Firm, Scientists Clash Over HIV Study, Chicago Tribune, Chicago: 4, Nov. 1.
19. Kassirer, J. (2004). On The Take: How Medicine's Complicity with Big Business Can Endanger Your Health. New York: Oxford University Press.
20. Korenman, S. G., Berk, R., Wenger, N. S., Lew, V., et al. (1998). Evaluation of the Research Norms of Scientists and Administrators Responsible for Academic Research Integrity, Jama, 279(1): 41-47.
21. Lexchin, J., Bero, L. A., Djulbegovic, B., Clark, O., et al. (2003). Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review, Bmj, 326(7400): 1167-1170.
22. Lipton, S., Boyd, E. A., Bero, L. A., et al. (2004). Conflicts of Interest in Academic Research: Policies, Processes, and Attitudes, Account Res, 11(2): 83-102.
23. Lo, B., Wolf, L. E., Berkeley, A., et al. (2000). Conflict-of-Interest Policies for Investigators in Clinical Trials, N Engl J Med, 343(22): 1616-1620.
24. Martin, J. B., and Kasper, D. L. (2000). In Whose Best Interest? Breaching the Academic-Industrial Wall, N Engl J Med, 343(22): 1646-1649.
25. Mello, M. M., Clarridge, B. R., et al. (2005). Academic Medical Centers' Standards for Clinical Trial Agreements with Industry, N Engl J Med, 352(21): 2202-2210.
26. Nathan, D. (1997). NIH Director's Panel on Clinical Research Report to the Advisory Committee to the NIH Director. Retrieved April 5, 2005. Available at http://www.nih.gov/news/crp/97report/.
27. Nathan, D. G., and Weatherall, D. J. (2002). Academic Freedom in Clinical Research, N Engl J Med, 347(17): 1368-1371.
28. Olivieri, N. F. (2003). Patients' Health or Company Profits? The Commercialisation of Academic Research, Sci Eng Ethics, 9(1): 29-41.
29. Rennie, D. (1997). Thyroid storm, Jama, 277(15): 1238-1243.
30. Saltus, R. (2000). AIDS Drug Researchers Say Firm Pressured Them. Findings Published, But Fight Goes to Court, Boston Globe, Boston: 3, Nov. 1.
31. Schafer, A. (2004). Biomedical Conflicts of Interest: A Defence of the Sequestration Thesis-Learning from the Cases of Nancy Olivieri and David Healy, J Med Ethics, 30(1): 8-24.
32. Schulman, K. A., Rubenstein, L. E., Glick, H. A., Eisenberg, J. M., et al. (1995). Relationships Between Sponsors and Investigators in Pharmacoeconomic and Clinical Research, Pharmacoeconomics, 7(3): 206-220.
33. Schulman, K. A., Seils, D. M., Timbie, J. W., Sugarman, J., Dame, L. A., Weinfurt, K. P., Mark, D. B. Califf, R. M., et al. (2002). A National Survey of Provisions in Clinical-Trial Agreements Between Medical Schools and Industry Sponsors, N Engl J Med, 347(17): 1335-1341.
34. Weatherall, D. (2003). Problems for Biomedical Research at the Academia-Industrial Interface, Sci Eng Ethics, 9(1): 43-48.